Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms. Issue 11 (30th November 2021)

• Record Type: Journal Article
• Authors: Barona-Gómez, Francisco; Delaye, Luis; Díaz-Valenzuela, Erik; Plisson, Fabien; Cruz-Pérez, Arely; Díaz-Sánchez, Mauricio; García-Sepúlveda, Christian A.; Sanchez-Flores, Alejandro; Pérez-Abreu, Rafael; Valencia-Valdespino, Francisco J.; Vega-Magaña, Natali; Muñoz-Valle, José Francisco; García-González, Octavio Patricio; Bernal-Silva, Sofía; Comas-García, Andreu; Cibrián-Jaramillo, Angélica
• Is Part Of: Microbial genomics. Volume 7:Issue 11(2021)
• Publication Date: 2021-11-30
• Subjects: SARS-CoV-2 -- population genomics -- nucleocapsid -- Mexico -- asymptomatic -- variants; Microbial genomics -- Periodicals; 572.8629
• DOI: 10.1099/mgen.0.000684
• Languages: English
• ISSNs: 2057-5858

Abstract

Abstract : Understanding the evolution of the SARS-CoV-2 virus in various regions of the world during the Covid-19 pandemic is essential to help mitigate the effects of this devastating disease. We describe the phylogenomic and population genetic patterns of the virus in Mexico during the pre-vaccination stage, including asymptomatic carriers. A real-time quantitative PCR screening and phylogenomic reconstructions directed at sequence/structure analysis of the spike glycoprotein revealed mutation of concern E484K in genomes from central Mexico, in addition to the nationwide prevalence of the imported variant 20C/S:452R (B.1.427/9). Overall, the detected variants in Mexico show spike protein mutations in the N-terminal domain (i.e. R190M), in the receptor-binding motif (i.e. T478K, E484K), within the S1–S2 subdomains (i.e. P681R/H, T732A), and at the basis of the protein, V1176F, raising concerns about the lack of phenotypic and clinical data available for the variants of interest we postulate: 20B/478K.V1 (B.1.1.222 or B.1.1.519) and 20B/P.4 (B.1.1.28.4). Moreover, the population patterns of single nucleotide variants from symptomatic and asymptomatic carriers obtained with a self-sampling scheme confirmed the presence of several fixed variants, and differences in allelic frequencies among localities. We identified the mutation N:S194L of the nucleocapsid protein associated with symptomatic patients. Phylogenetically, this mutation is frequent in Mexican sub-clades. Our results highlight the dual and complementary role of spike and nucleocapsid proteins in adaptive evolution of SARS-CoV-2 to their hosts and provide a baseline for specific follow-up of mutations of concern during the vaccination stage.